Are long-term remissions possible with hormonal therapy only? Post hoc analysis of EMBARK examining sustained prostate-specific antigen (PSA) <0.2 ng/mL despite testosterone (T) recovery after treatment (tx) suspension.
| Published in: | Journal of Clinical Oncology Vol. 44; pp. 189 - 474 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2026 Supplement 7
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |